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A fetus is inherently antigenic to its mother and yet is not rejected.
The T regulatory (Treg) subset of CD4+ T cells can limit immune
responses and has been implicated in maternal tolerance of the
fetus. Using virgin inbred mice undergoing a ﬁrst syngenic preg-
nancy, in which only the male fetuses are antigenic, we demon-
strate a maternal splenocyte proliferative response to the CD4+ T
cell restricted epitope of themale antigen (H-Y) in proportion to the
fetal antigen load. A portion of the maternal immune response to
fetal antigens is Treg in nature. The bystander suppressive function
of pregnancy-generated Tregs requires the presence of the fetal an-
tigen, demonstrating their inherent antigen speciﬁcity. In vivo tar-
geting of diphtheria toxin to kill Tregs leads to a lower fraction of
livemale offspring and a selective reduction inmass of the surviving
males. Thus, Tregs generated in the context of pregnancy function in
an antigen-speciﬁc manner to limit the maternal immune response
to the fetus in a successful pregnancy.
denileukin diftitox | Medawar | H-Y
Maternal tolerance of the fetal allograft has been a subject ofresearch since Medawar formalized the apparent paradox of
its maintenance (1). It is clear from both animal and human studies
that the lack ofmaternal rejection of the fetus is not due tomaternal
immunologic ignorance of the fetus (2, 3). There is signiﬁcant
admixingofmaternal and fetal cells in theother’s compartments (4).
Potent mechanisms of immune regulation must be activated during
pregnancy to prevent rejection. However, these inhibitory mecha-
nisms must only be directed against antigens of the fetus so that
other immune responses can continue to protect the mother.
Mechanisms of peripheral immune tolerance invoke a central
role for the regulation of CD4+ T cell activation and function (5).
The diverse inhibitory as well as stimulatory roles for subsets of
CD4+ T cells (6) implies that fate determination of CD4+ T cells
may be an important mechanism limiting the occurrence of auto-
immunity in healthy individuals. The robust regulatory capacity of
Tregs has led to signiﬁcant interest in the development and function
of these specialized cells. The mechanisms underlying the function
of Tregs are of intense interest given their obvious therapeutic po-
tential.Various linesof investigationpoint towarddirect cell contact
or soluble mediators (7). Accumulating circumstantial evidence
suggests that Tregs can provide an antigen-driven bystander sup-
pression function (8).
Application of the knowledge of Tregs to the maintenance of
pregnancy has yielded intriguing observations. Adoptive transfer
reconstitution of BALB/c nude mice with lymphocytes depleted of
Tregs results in smaller litters from allogenic matings (9). Treg
populations peak in peripheral blood lymphocytes during the second
trimester of human pregnancies and accumulate in the decidua (10).
To explore the nature of CD4+ T cell responses to fetal anti-
gens, we chose a simple in vivo system: the maternal response of
inbred mice during their ﬁrst pregnancy to a male antigen. Male
cells bear a minor transplantation antigen (H-Y), the reaction to
which causes female mice to reject tissue grafts from male litter-
mates (11, 12). From transplantation experiments, the CD8 and
CD4 T cell epitopes of H-Y have been described (13–15). Details
regarding CD4+ responses to H-Y during pregnancy have relied
on the artiﬁcial system of a reconstituted RAG−/− mouse with T
cells carrying a transgenic TCR having speciﬁcity for the CD4+
epitope (Dby) (16). We sought to understand the CD4+ T cell
reactions in the unperturbed setting.
Results
Previous Pregnancy Imparts CD4+ T Cell Awareness to a Male Antigen.
To test the hypothesis that pregnancy generates immunologic
awareness of the fetuses, we evaluated inbred female C57BL/6
mice that had previously been pregnant (parous). Using a MHC
class II (I-Ab) restricted CD4+ T cell H-Y antigenic peptide epi-
tope (Dby) or a similarly restricted peptide epitope control from
listeriolysin (Lso) as a source of stimulation, splenocytes from
parous or virgin mice were tested for a proliferative response
by 3[H]thymidine uptake (Fig. 1A, Right). The cells from parous
mice were found to have a signiﬁcant increase in proliferation
when stimulated with Dby vs. Lso (or no peptide stimulation)
reﬂecting a previous CD4+ T cell encounter with H-Y antigen. As
expected, virgin mice do not display such immunologic awareness
and do not differ in their (background) proliferative response to
Lso as opposed to Dby (Fig. 1A, Left).
We turned to mice in their ﬁrst pregnancy, examining maternal
splenocyte proliferative responses to Dby (vs. Lso) at three ges-
tational time points: days postcoitus (dpc) 6.5, 12.5, and 18.5.
Virginmice did not showa signiﬁcant proliferative response toDby
compared with Lso (Fig. 1B). At dpc 6.5 in mice with conﬁrmed
and enumerated embryos, we did not observe a stimulatory effect
of Dby. At dpc 12.5, splenocytes showed a signiﬁcant response to
Dby (compared with Lso) with further increase in net stimulation
by dpc 18.5 (Fig. 1B).
Pregnancy Primes Maternal CD4+ T Cell Awareness in Proportion to
Fetal Antigenic Mass.Different mothers carry different numbers of
male mice, giving the possibility of seeing a natural dose response.
Early in gestation (dpc 6.5), when no detectable maternal CD4+ T
cell proliferation in response toDbywas evident (Fig. 1C), wewere
unable to identify the fetal gender by PCR using either SRY or
H-Y ampliﬁcation, but we believe that this is a result of insufﬁcient
antigen because it is statistically unlikely that all of the concepti
were female. By dpc 12.5, a detectable splenocyte proliferative
responsewas found toDby in somepregnancies.At this gestational
age, having more male fetuses increased the probability of seeing
a signiﬁcant response toDby as compared with Lso. A mouse with
three male fetuses displayed no signiﬁcant proliferative response
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to Dby (Fig. 1D; albeit showing a trend to higher response). A
mouse with four male fetuses had a statistically signiﬁcant re-
sponse toDby, and a mouse with ﬁve male fetuses had a yet higher
response, demonstrating a fetal antigenic dose relationship to the
maternal CD4+ T cell response at this gestational age. As the fetal
mass increased with advancing gestation, the magnitude of the
maternal CD4+ T cell sensitivity to Dby stimulation increased so
that two male fetuses were as efﬁcient as four for eliciting a ma-
ternal CD4+ T cell proliferative response to Dby (Fig. 1E), al-
though at an earlier gestation, three males were insufﬁcient.
Pregnancy Primes a T Regulatory Response to Male Fetal Antigen.
Tregs selectively express the transcription factor FoxP3 (17). To
evaluate the role of Tregs induced during pregnancy, we examined
changes in theproportionofFoxP3-expressingmaternalCD4+cells
in various lymphoid compartments of virgin, ﬁrst pregnancy, and
parous C57BL/6 mice. Cells from various lymphoid organs were
evaluated by FACS for the proportion that was CD4+FoxP3+
(Treg). There was a non-statistically signiﬁcant trend toward in-
creasing Treg proportions with respect to advancing gestational age
as comparedwith virginmice (Fig. 2). This trendpersisted in parous
mice. There does not appear to be a signiﬁcant regional accumu-
lationofTregs ina speciﬁc lymphoid compartment in these syngenic
mating, but inmore disparate crosses, an increase in the proportion
of Tregs has been reported (9).
To probe the functional nature of Tregs in pregnant mice, we
examined the consequences of depletion of Tregs on the pro-
liferative response of maternal lymphocytes to H-Y antigen. To
remove Tregs, we depleted cells bearing CD25 on the cell surface,
which should greatly reduce Tregs (18). Day 18.5 whole splenocytes
from a C57BL/6 mouse in her ﬁrst pregnancy with six male fetuses
displayed a proliferative response similar to that seen previously
for other dpc 18.5 mice (Fig. 1E). After depletion of CD25+ cells,
the proliferative response to Dby increased 3-fold (Fig. 3A). In
contrast, depletion of CD25+ cells from splenocytes from virgin
mice that do not proliferate to Dby (Figs. 1 A and B, and Fig. 3B)
did not similarly unmask a proliferative response. With increasing
fetal antigenic mass, there is an increased proliferative response to
speciﬁc fetal antigen (Fig. 1B). Similarly, there is an increasing ef-
fect of CD25+ depletion on the augmentation of the proliferative
response to Dby in proportion to the fetal antigenic burden (Fig.
3C). In addition, there appears to be a residual augmentation of
splenocyteproliferative response toDby inparousmicewithCD25+
cell depletion (Fig. 3C). This last ﬁnding suggests that pregnancy
develops a lasting functional Treg population in response to the
presence ofmale fetuses. To be sure that we had removedTregs, we
directly characterized the effect of CD25+ depletion on the Treg
(CD4+FoxP3+) population. Depletion of CD25+ cells decreased
Fig. 1. Pregnancy imparts CD4+ T cell awareness. (A) Splenocytes harvested
from virgin (8 weeks old, n = 4) and previously bred (14 weeks old, n = 4)
C57BL/6 mice from the same colony: Cellular proliferation assay performed
using 1 × 106 cells per mL to the CD4+ T cell peptide epitope of the H-Y
antigen presented by I-Ab (10 μM Dby), the I-Ab presented lysteriolysin
peptide epitope (10 μM Lso), or no peptide stimulation. Cultures were pulsed
with 1 μCi per well 3[H]TdR for the ﬁnal 18 h of a 72-h culture (cpm ± SD).
Statistical difference determined by one-way ANOVA with Bonferroni–Dunn
posttest (N.S., nonsigniﬁcant; *, P < 0.05). Pregnancy primes maternal CD4+ T
cell awareness in proportion to fetal antigenic mass. (B) Splenocytes har-
vested from virgin 8-week-old C57BL/6 mice (8 weeks, n = 4) and timed ﬁrst
pregnancy of 8-week-old female C57BL/6 × C57BL/6 males (n = 4 each time
point) at days post coitus (dpc 6.5, 12.5, 18.5): Cellular proliferation assay
performed using 1 × 106 cells per mL to the CD4+ T cell peptide epitope of
the H-Y antigen presented by I-Ab (10 μM Dby) or the I-Ab presented lys-
teriolysin peptide epitope (10 μM Lso). Cultures were pulsed with 1 μCi per
well 3[H]TdR for ﬁnal 18 h of a 72-h culture. Composite fold increase in
proliferation with Dby/Lso ± SEM. Statistical difference determined by one-
way ANOVA with Bonferroni–Dunn posttest (*, **, #, P < 0.05). (C) Days
postcoitus 6.5. Splenocyte proliferative response determined for individual
mice ± SD along with fetal gender determination. (D) Days postcoitus 12.5.
(E) Days postcoitus 18.5. Statistical difference determined by two-tailed,
unpaired Student’s t test (N.S., nonsigniﬁcant; *, P < 0.05).
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the CD4+FoxP3+ population to a similar extent (80–90%) in all
samples tested (Fig. S1).
Pregnancy-Induced Treg Suppressive Function Is Antigen Speciﬁc.We
sought to determine whether Tregs generated during pregnancy
were capable of bystander suppression, as has been previously
reported in other nonpregnancy systems (7), andwhether bystander
suppression is an antigen-speciﬁc phenomenon. To examine this
question, we evaluated the ability of pregnancy-induced Tregs to
suppress an in vitro lymphocyte response to amodel antigen (KLH)
raised in a separate mouse. Splenocytes were isolated from a four-
male pregnant mouse on dpc 18.5 and from a virgin female mouse
immunized with KLH/CFA 7 days previously. Splenocytes from the
pregnant mouse showed a proliferative response when stimulated
with Dby vs. Lso. Additionally, these splenocyte cultures from the
pregnantmousedidnot showaproliferative response toKLHabove
basal proliferation (Fig. 4A). Conversely, the virgin mouse immu-
nized with KLH/CFA did not show a proliferative response to Dby
Fig. 2. Regional distribution of T regulatory cells in relation to ﬁrst syngenic
mating. Single-cell suspensions from indicated lymphoid organs prepared
from virgin (n = 3) or timed ﬁrst pregnancies from C57BL/6 syngenic mating
(dpc 6.5, n = 4; dpc 12.5, n = 6; dpc 18.5, n = 6), or retired from syngenic
breeding (n = 4). FACS performed with gating on CD4+ cells to determine the
fraction of FoxP3+ cells. Statistical differences determined by one-way
ANOVA with Bonferroni–Dunn posttest (N.S., nonsigniﬁcant).
Fig. 3. Pregnancy results in a functional T regulatory response in proportion
to the fetal mass. (A) Splenocytes harvested from a timed ﬁrst pregnancy of
a 6-week-old C57BL/6 × C57BL/6 male at dpc = 18.5 (six male fetuses). Sple-
nocyte proliferative response determined for individual mice ± SD. (B) Sple-
nocytes from virgin 6-week-old C57BL/6 (no prior plugs). Treg depletion by
magnetic bead separation of CD25+ cells. Cellular proliferation assay was
performed using 1 × 106 cells per mL to the CD4+ T cell peptide epitope of the
H-Y antigen presented by I-Ab (10 μM Dby) or the I-Ab presented lysteriolysin
peptide epitope (10 μM Lso). Cultures were pulsed with 1μCi per well 3[H]TdR
for theﬁnal 18hof a 72-h culture (cpm± SD). Statistical differencedetermined
by two-tailed unpaired Student’s t test (N.S., nonsigniﬁcant; *, P < 0.05). (C)
Splenocytes from virgin, timed ﬁrst pregnancy of C57BL/6 × C57BL/6 (8 weeks
old, n = 4 each time point) dpc 6.5, 12.5, and 18.5, or 14-week-old retired
breeder (parous). Depletion of CD25+ cells (Treg) by magnetic bead. Com-
posite fold increase in proliferation with Dby (CD25+ depleted)/Dby (whole
splenocytes) ± SEM. Statistical difference determined by one-way ANOVA
with Bonferroni–Dunn posttest (*, **, #, †, ‡, P < 0.05).









above the basal level, but did have a signiﬁcant response to KLH.
When the splenocytes from the pregnant mouse were depleted of
CD25+ cells (Tregs), the proliferative response to Dby was aug-
mented whereas the responses to Lso (basal proliferation) or KLH
were unaffected (Fig. 4B). Similarly, CD25+ cell depletion from
splenocyte cultures from KLH/CFA-immunized mice generated
a signiﬁcant increase in proliferation to KLH when compared with
nondepleted splenocyte cultures, yet the proliferative responses to
Lso or Dby in these virgin mouse cells remained unaffected (Fig.
4B).Of note, we deliberately did not provoke amaximal response to
KLH to keep the proliferation in line with the subtle nature of the
antipregnancy response.
When the CD25+ cells (Tregs) were added back to previously
CD25+ depleted splenocytes from the pregnant mouse, the re-
sulting proliferation matched the unperturbed splenocyte culture
(Fig. 4C).When theCD25+ cells (Tregs) from the pregnantmouse
were cocultured with CD25+-depleted splenocytes from theKLH/
CFA-immunized mouse (ratio of Treg/CD25+ depleted spleno-
cytes = 1:4) the culture showed an unchanged proliferative re-
sponse to KLH despite the physical presence of additional Tregs
(Fig. 4D). When Dby and KLH were added to the mixed CD25+
cell–depleted splenocytes from KLH/CFA-immunized mice and
CD25+ cells from the pregnant mouse, the proliferative response
toKLHwas efﬁciently suppressed (Fig. 4D). Thus, the suppressive
effects of the CD25+ cells (Treg) from the pregnant mouse were
only manifest in the presence of Dby, reﬂecting an antigen re-
quirement for activation of the bystander suppressive effect. In
contrast, CD25+ cells isolated from KLH immunized mice and
cocultured with CD25+-depleted splenocyte cultures from preg-
nant mice did not show a corresponding ability to perform by-
stander suppression when activated with KLH and Dby (Fig. 4D).
In both cases, a similar absolute number of CD4+FoxP3+ cells
were present in the cultures [9,970 pregnancy-derived Tregs vs.
12,800 KLH/CFA-derived Tregs (Fig. S2)]. We did ﬁnd that lim-
ited fetal antigen exposure (one to two male fetuses on dpc 12.5)
generated no detectable bystander suppressive effect (Fig. S3 A
and B, respectively).
Depletion of Tregs in Vivo During Pregnancy Leads to Rejection of
Male Fetuses. CD25 is the IL-2 receptor protein and denileukin
diftitox is a recombinant protein consisting of IL-2 linked to
diphtheria toxin (19). This FDA-approved drug (for recurrent
cutaneous T cell lymphoma) has been shown in mice to partially
deplete (by up to 50%)Tregs in vivo over the course of 3 days (19).
We treated C57BL/6 mice in their ﬁrst pregnancy (syngenic) with
three equal doses of the drug on dpc 6.5, 12.5, and 15.5. Evaluation
of the Treg populations on dpc 18.5 in various lymphoid organs
found that only in the pelvic/periaortic lymph nodes was there
a signiﬁcant decrease in Tregs (Fig. 5). This ﬁnding is consistent
with the known recovery of Treg populations over the course of 3
days posttreatment (19). However, the pelvic nodes may be par-
ticularly susceptible to Treg depletion because these lymph nodes
are the draining sites for the peritoneum and, as such, may have
had the highest local dose of denileukin diftitox. Despite relatively
unchanged Treg populations on dpc 18.5, we did observe adverse
pregnancy outcomes in the treatedmice vs. saline-treated controls.
First, there is a striking reduction in the proportion of males
among litters from mice treated with denileukin diftitox (25.6 ±
3.8%) vs. saline-treated controls (41.8 ± 3.4%) (Fig. 6A). Second,
the weight of the male fetuses (0.86 ± 0.12 g) was reduced com-
pared with the females (1.02 ± 0.02 g) from mice treated with
denileukin diftitox. This observation was dominated by two par-
ticularly smallmales, butmany of themale fetuses weighed asmuch
as females. In saline-treated control mice, the weights were equiv-
alent between the male (1.22 ± 0.02 g) and female (1.20 ± 0.01 g)
fetuses (Fig. 6B). Our in vitro evaluation of splenocyte response to
Dby stimuli compared with Lso from denileukin diftitox–treated
mice found that, as would be expected, further depletion of CD25+
Fig. 4. Pregnancy-induced T regulatory cells suppressive function is antigen-
speciﬁc. (A) Splenocytes harvested from a timed ﬁrst pregnancy of 6-week-
old C57BL/6 × C57BL/6 male at dpc 18.5 (four male fetuses) as well as virgin 6-
week-old C57BL/6 female immunized with KLH/CFA 7 days prior. Cellular
proliferation assay was performed using 1 × 106 cells per mL to the CD4+ T
cell peptide epitope of the H-Y antigen presented by I-Ab (10 μM Dby), the
I-Ab presented lysteriolysin peptide epitope (10 μM Lso) or KLH (1 μg/mL).
Cultures were pulsed with 1 μCi per well 3[H]TdR for the ﬁnal 18 h of a 72-h
culture. (B) CD25+ reduced splenocytes. (C) Splenocytes harvested from
a timed ﬁrst pregnancy of 6 weeks – old C57BL/6 x C57BL/6 male at dpc 15.5
(three male fetuses). CD25+ cell reduced. CD25+ cells (Treg) added back to
CD25+-depleted splenocytes in a ratio of 4:1. (D) CD25+-reduced splenocytes
from either the dpc 18.5 mouse (□) or the KLH/CFA-immunized mouse (■)
above cocultured with the CD25+ (Treg enriched population) isolated by
magnetic bead positive selection from the KLH/CFA-immunized mouse (□)
or the pregnant mouse (■) at a ratio of 4:1. Stimuli as indicated (Lso 10 μM,
Dby 10 μM, KLH 1 μg/mL). Statistical difference determined by one-way
ANOVA with Bonferroni–Dunn posttest (N.S., nonsigniﬁcant; *, P < 0.05).
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cells from splenocyte cultures did not augment the proliferative
response to Dby to nearly the same extent as in saline-treated con-
trolmice (Fig. 6C). This lastﬁndingmight indicate that although the
population of Tregs overall is unperturbed, the H-Y–speciﬁc Tregs
were selectively diminished in vivo.
A pregnant outbred mouse faces an immunologic challenge of
dramatic proportions in the foreign nature of the many fetal anti-
gens. By using inbred mice, we have chosen to focus on a single
antigenic difference: the maternal response to male fetuses during
ﬁrst pregnancy as evidenced by a recall response to male antigen in
cells fromparousmicebut not those fromvirginmice. It is important
to note that in our system, we deliberately used virgin (no prior
vaginal plug) mice because in some systems mucosal exposure to
male antigens is sufﬁcient to prime an immune response (20).
Discussion
As the fetal mass increases with increasing gestational age and
number of male concepti, the maternal CD4+ T cell response
increases. This maternal CD4+ T cell response to H-Y involves at
least two cell types, active helper T cells and Tregs. Removing the
Tregs reveals the magnitude of the active T cell response, showing
that both forms of response are occurring. The suppressive ability
of the Tregs isolated was in proportion to antigenic stimulus (i.e.,
the mass of fetal antigen). Pregnancy apparently leads to a ma-
ternal immune response to the fetus strongly suppressed by the
Treg component. This is at least one reason why mothers do not
reject their babies as evidenced by compromising the Treg re-
sponse with denileukin diftitox, which generated selective re-
jection of male fetuses. It would appear that exposing mice over
much of their pregnancy to an environment lacking sufﬁcient
Tregs leads to embryo rejection.
To understand the role of antigen in suppression, we examined
the bystander effect of antigen-driven Tregs. For the cells de-
veloped during pregnancy, antigen was required for them to sup-
press a KLH response; the simple presence of unstimulated Tregs
had no effect. Bystander suppression was not reciprocal: KLH-
speciﬁc Tregs suppressed a KLH response but even with added
antigen did not display bystander activity against the H-Y re-
sponse. The difference in bystander suppressive capability might
relate to the proportion of the Tregs that are speciﬁc to the antigen
rather than the absolute number of CD4+FoxP3+ cells. Con-
ditions that favor the development of Tregs (pregnancy) likely
increase a functional subset of CD4+CD25+FoxP3+ cells without
affecting the overall population of Tregs. Immunization with CFA
is inherently inﬂammatory and generates an immune response that
may be dominated by effector CD4+ cells, especially at the early
time we studied.
The antigen-dependent bystander suppression by pregnancy-
induced Tregs is evident in this system, but the requirements of
Treg-induced suppression as seen in other systems is controversial
(7, 8). Some investigations have found such a requirement where
as others have not, but all of these studies have used artiﬁcial
systems like TCR transgenic mice (7, 21–24). Pregnancy, though
a complicated stimulus, produces Tregs as part of a natural re-
sponse. In all of these cases, the study of Treg functionality has
been limited by the inability to deliberately induce an antigen-
speciﬁc Treg population.We found that as an intrinsic property of
Fig. 5. In vivo effect of denileukin diftitox on Treg populations in regional
lymphoid organs. Shown is FACS analysis of indicated single-cell suspensions
immediately ex vivo stained for CD4 and FoxP3 from timed ﬁrst pregnancy
of C57BL/6 × C57BL/6 at dpc 18.5. Saline, n = 6; denileukin diftitox, n = 4.
Statistical difference was determined by two-tailed, unpaired Student’s t test
(N.S., nonsigniﬁcant; *, P < 0.05).
Fig. 6. In vivo reduction in Tregs results in poor pregnancy outcome speciﬁc
to fetal antigens. (A) Percentage male fetuses determined for each litter of
C57BL/6 × C57BL/6 by PCR from Saline-treated (●) (n = 8) or denileukin
diftitox–treated (○) mice (n = 4). (B) On dpc 18.5, fetal weights determined
for fetuses from the above mating. (C) Splenocytes harvested from the
saline-treated (●) (n = 5) or denileukin diftitox–treated (○) (n = 4) mice, and
cellular proliferation assay performed using 1 × 106 cells per mL to the CD4+
T cell peptide epitope of the H-Y antigen presented by I-Ab (10 μM Dby) or
the I-Ab presented lysteriolysin peptide epitope (10 μM Lso). Cultures were
pulsed with 1 μCi per well 3[H]TdR for the ﬁnal 18 h of a 72-h culture. De-
pletion of CD25+ cells (Treg) by magnetic bead. Composite fold increase in
proliferation with Dby (CD25+ depleted)/Dby (whole splenocytes). Statistical
difference was determined by two-tailed, unpaired Student’s t test (N.S.,
nonsigniﬁcant; *, P < 0.05).









pregnancy, a population of Tregs develops suppressive function
in proportion to the fetal antigens with which the mother must
cope. Furthermore, because the fetal antigen in our simple system
is well deﬁned (H-Y), we have been able to demonstrate that the
Tregs gain suppressive reactivity to this antigen and are capable
of bystander suppression. Pregnancy provides a unique situation in
which a population of Tregs can be naturally expanded and their
physiologic function explored.
Our ﬁndings here provide a framework to investigate two fun-
damental issues in immune tolerance. First, the highly speciﬁc and
important role that Tregs play in the success of a pregnancy can be
explored to examine such questions as what characteristics of
pregnancy lead to a Treg response and the conditions that lead to
the breakdown of tolerance in pregnancy-speciﬁc diseases. Sec-
ond, the use of pregnancy to generate a population of Tregs with
a deﬁned biological role may facilitate our understanding of this
important T cell subset.
Materials and Methods
Mice. C57BL/6micewereobtained fromanexistingbreedingcolonyatCaltech.
The colony is housed in a barrier facility used for transgenic mice generation.
The mice were subjected to timed matings between previously successful
breeder males aged 8–12 weeks and virgin (no prior plugs) females aged 5–6
weeks. The day of vaginal plug observationwas denoted as dpc 0.5.Micewere
housed and handled in accordance with National Institutes of Health guide-
lines under InstitutionalAnimal Care andUseCommittee–approvedprotocols.
Reagents. Keyhole limpet hemocyanin (KLH) was purchased from Calbiochem.
Freund’s adjuvant andMycobacterium tuberculosis were obtained from Difco.
Complete Freund’s adjuvant (CFA) was prepared as 4 mg/mLM. tuberculosis in
a 1:1 (vol/vol) emulsion of Freund’s adjuvant and PBS. CD4+ T cell I-Ab restricted
epitopes for H-Y (Dby608–622) NAGFNSNRANSSRSS (15) and irrelevant I-A
b re-
stricted peptide epitope Listeriolysin O (Lso190–201) were prepared by custom
solid-phase synthesis (New England Peptide).
Proliferation Assays. Spleens were harvested and prepared into a single-cell
suspension with a metal screen (300 μm). RBCs were lysed by a room temper-
ature incubation in a hypotonic solution [0.83% NH4Cl, 0.02 M Tris (pH 7.6)].
Cells were plated in round-bottom, 96-well tissue culture plates at 1 × 106 cells
per mL in RPMI medium 1640 (GIBCO) supplemented with 10% (vol/vol) heat-
inactivated, 5.5 × 10−5 M 2-ME, 100 units/mL penicillin, 100 units/mL strepto-
mycin, and 2.5 mM L-glutamine. Cells were cultured at 37 °C with 5% CO2 in
a humidiﬁed incubator. Cells assayed for proliferation were pulsed with 1 μCi
per well 3[H]thymidine for the ﬁnal 18 h.
Lymphoid Organ Preparation. Whole blood was collected by cardiac puncture.
Lymphocytes were isolated using a Ficoll gradient. Inguinal and pelvic/periaortic
lymph nodes were collected and single-cell suspensions prepared by passing the
tissue through a 70-μmpolypropylene mesh cell strainer (BD) in PBS on ice.
Flow Cytometry and Cell Separation. Fluorescently labeled monoclonal anti-
bodies to CD4 and FoxP3 were obtained from BioLegend. Staining was done
using the Foxp3 staining buffer set according to the manufacturer’s
instructions (eBioscience). CD25 depletion was accomplished by magnetically
labeled antibody mediated columns according to the manufacturer’s
instructions (Miltenyi Biotec). Analysis was performed on a BD FACSCalibur
with postacquisition analysis performed with FlowJo (Tree Star).
Fetal Gender Identiﬁcation. Fetal tissue was placed in 75 μL of base solution
[0.025 M NaOH, 0.2 mM EDTA (pH 12)] and incubated at 95 °C for 30 min. To
this was added 75 μL of neutralization solution [0.04 M Tris·HCl (pH 5.0)]. The
supernatant was used as DNA template in a PCR (Platinum Amplitaq; Invi-
trogen) with primers for murine SRY, 5′-TTGTCTAGAGAGCATGGAGGGCC-
ATGTCAA-3′ and 3′-AGCCTCCCGATTTCACAGTGTCTCCTCACC-5′. In the same
reaction were included control primers for Fabpi, 5′-CCTCCGGAGAGCAGCGA-
TTAAAAGTGT-3′ and 3′-TAGAGCTTTGCCACATCACAGGTCATTCA-5′. The ampli-
con of SRY is 268 bp and of Fabpi is 455 bp.
In Vivo Treg Depletion. Mice were treated with denileukin diftitox (Eisai) 100
μg/200 μL PBS or PBS alone i.p. on dpc 6.5, 12.5, and 15.5.
Statistical Analysis. Differences were statistically analyzed using unpaired
Student’s t test or analysis of variance (ANOVA) with Bonferroni/Dunn
posttest. Analysis was accomplished with PRISM (GraphPad).
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